Multicenter validation of plasma p-tau217/ amyloid beta 1-42 ratio in symptomatic Alzheimer's disease.
- DOI
- 10.1002/alz.71644
- Published
- 2026 Jul
- Container
- Alzheimer's & dementia : the journal of the Alzheimer's Association
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/alz.71644,
title = {Multicenter validation of plasma p-tau217/ amyloid beta 1-42 ratio in symptomatic Alzheimer's disease.},
author = {Moghekar AR and Rock JA and Mohs RC and Hansson O and Stomrud E and Palmqvist S and Mattsson-Carlgren N and Johnson SC and Zetterberg H and Radwan RR and Junfola J and Miller MC and Buitrago L and De Simone FI and Martin K and Dickson D and Benina N and Hawkins DM},
year = {2026},
journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
doi = {10.1002/alz.71644},
url = {https://doi.org/10.1002/alz.71644}
}RIS
TY - JOUR TI - Multicenter validation of plasma p-tau217/ amyloid beta 1-42 ratio in symptomatic Alzheimer's disease. AU - Moghekar AR AU - Rock JA AU - Mohs RC AU - Hansson O AU - Stomrud E AU - Palmqvist S AU - Mattsson-Carlgren N AU - Johnson SC AU - Zetterberg H AU - Radwan RR AU - Junfola J AU - Miller MC AU - Buitrago L AU - De Simone FI AU - Martin K AU - Dickson D AU - Benina N AU - Hawkins DM PY - 2026 JO - Alzheimer's & dementia : the journal of the Alzheimer's Association DO - 10.1002/alz.71644 UR - https://doi.org/10.1002/alz.71644 ER -
APA
AR, M., JA, R., RC, M., O, H., E, S., S, P., N, M., SC, J., H, Z., RR, R., J, J., MC, M., L, B., FI, D. S., K, M., D, D., N, B., & DM, H. (2026). Multicenter validation of plasma p-tau217/ amyloid beta 1-42 ratio in symptomatic Alzheimer's disease.. Alzheimer's & dementia : the journal of the Alzheimer's Association. https://doi.org/10.1002/alz.71644
Source records
- pubmed · retrieved 2026-09-25T10:34:48.227Z